Member Exclusive News

The week in industry: US FDA approves first FGFR kinase inhibitor

This week: Enesi Pharma (Abingdon, UK) enter into partnership to develop new vaccines against influenza, US FDA accept application from Norvatis (Basel, Switzerland) to expedite review of drug to treat wet age-related macular degeneration and Phase I/IB trial initiated for patients with advanced cancer.

Please sign in or register for FREE

No comments yet.